Newsfeeds - Spark Newswire

1 minute read

FDA
News

Enlivex Earlier National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘Phase 2b…Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19…’

By Benzinga Newsdesk

Today, 1:14 PM

https://clinicaltrials.gov/ct2/show/NCT04922957

ENLV

6 minute read

Uncategorized

65 Biggest Movers From Yesterday

By Lisa Levin

Today, 1:14 PM

Gainers ShiftPixy, Inc. (NASDAQ: PIXY) jumped 33.1% to settle at $3.34 on Thursday as the company said it has been named as sponsor related to 4 SPACs.

ADS

Latest news

Enlivex Earlier National Institutes Of Health ClinicalTrials.gov Study Record Detail For Co.’s ‘Phase 2b…Study, Evaluating Efficacy and Safety of Allocetra-OTS in Patients With Severe or Critical COVID-19…’

65 Biggest Movers From Yesterday